Gaucher disease is a genetic disorder when the body is unable to break down certain fats, leading to fat accumulation in the ...

"Health being a state subject, the primary responsibility of providing healthcare services is that of state governments. However, to mitigate the challenges posed by rare diseases in India, the Union ...

The following is a summary of “Cutaneous manifestations of Fabry disease: A systematic review,” published in the March 2025 ...

Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental Despite medical advances, heart disease has remained the leading cause of death in the U.S. for more than a century, ...

Crohn’s disease is an autoimmune disease and a type of inflammatory bowel disease (IBD). If you have one autoimmune disease, like Crohn’s, you are more likely to have another autoimmune disease.

Q4 2024 Earnings Call Transcript March 17, 2025 Sangamo Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.11 EPS, expectations were $-0.09. Operator: Good afternoon, and welcome ...

Sangamo Therapeutics Inc (SGMO) reports significant progress in its Fabry disease program and neurology therapies, while navigating financial hurdles and partnership negotiations.

Julia Alton was 18 years old when she lost her dad to the same disease he had passed on to her. Fabry disease is a rare metabolic disorder that affects many parts of the body. According to Dr. Michael ...

Amicus Therapeutics, Inc. (NASDAQ:FOLD) is a biotech company engaged in the discovery, development, and delivery of medicines to treat metabolic diseases. Amicus introduced the first and only approved ...

Background: Fabry disease (FD) is an X-chromosome-linked genetic disorder. Currently, the main treatments for FD include disease-nonspecific and disease-specific treatments. Nonspecific treatment ...

WYFF 4 introduced you to Dr. Brian Jones and his wife, Tia, in February on an episode of "4 The Record" about rare diseases and early intervention. Jones is living with Fabry disease. He didn't ...